Clinical Trials Logo

Spondylitis clinical trials

View clinical trials related to Spondylitis.

Filter by:

NCT ID: NCT05010720 Completed - Frailty Clinical Trials

Prevelance of Frailty and Its Associated Factors in Patients With Axial Spondyloarthritis

Start date: August 12, 2021
Phase:
Study type: Observational

Axial Spondyloarthritis is an inflammatory arthritis disease and its main symptoms are chronic pain and stiffness, causing structural damage to the spinal vertebrae. Axial Spondyloarthritis leads to physical disability and a decrease in the level of physical activity. Frailty is a syndrome characterized by decline in physiological reserve and loss of muscle strength. Frailty can lead to vulnerability of individuals to possible injuries and a decrease in independence, and ultimately an increase in mortality. Although frailty is associated with older adults, it has been reported that it can be detected in patients with cancer, diabetes and rheumatological diseases and it is not related with age. Frailty has been reported to be a reversible and a treatable condition. The aim of our study was to investigate the prevalence of frailty and the relationship between frailty and disease activity, physical functional level, quality of life and other associated factors in individuals with Axial Spondyloarthritis.

NCT ID: NCT04943237 Completed - Clinical trials for Ankylosing Spondylitis

Anti-TNF Therapy and Nerve Conduction Studies in Ankylosing Spondylitis

Start date: July 1, 2019
Phase:
Study type: Observational

Patients with ankylosing spondylitis were divided into 2 groups as anti-TNF and conventional therapy according to the treatments they were using for the last 5 years. Nerve conduction studies in the upper and lower extremities of the patients were compared.

NCT ID: NCT04922840 Completed - Clinical trials for Rheumatoid Arthritis

Improved Cardiovascular Health for Patients With Inflammatory Joint Diseases

ExeHeart
Start date: August 9, 2021
Phase: N/A
Study type: Interventional

Inflammatory joint diseases (IJD) are autoimmune diseases with common symptoms of joint inflammation, pain, stiffness and fatigue. Compared to the general population, this large patient-group has an increased risk of cardiovascular disease (CVD) and CVD-related mortality. Patients with IJD call for improved CVD screening and risk management as well as access to evidence-based non-pharmacological treatment alternatives. Evidence supports high intensity training (HIIT) in mitigating risk of CVD and inflammation, but the evidence of these cardioprotective benefits is unclear in patients with IJD and the feasibility of HIIT protocols in daily clinical care needs to be addressed. Cardiorespiratory fitness (CRF) is an important physiological marker and highly correlated to risk of CVD. Despite strong recommendations, routine assessment of CRF is seldom performed in clinical care. The ExeHeart study will assess the potential cardioprotective and disease-modifying effect of HIIT in IJD in a randomized controlled trial. Furthermore, the ExeHeart-study will report on the validity of non-exercise measures of cardiorespiratory fitness (eCRF) measures for use in daily clinical care. Additionally, we will explore the feasibility of HIIT by addressing adherence and fidelity to the HIIT treatment protocol in a primary care setting

NCT ID: NCT04840485 Completed - Clinical trials for Ankylosing Spondylitis

Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis

Start date: June 9, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SHR-1314 in patients with active ankylosing spondylitis

NCT ID: NCT04810715 Completed - Clinical trials for Spondylitis, Ankylosing

Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction in Patients With Ankylosing Spondylitis

Start date: March 1, 2021
Phase:
Study type: Observational

This investigation aims to investigate the frequency of pes planus and posterior tibial tendon dysfunction in patients with ankylosing spondylitis.

NCT ID: NCT04803383 Completed - Clinical trials for Ankylosing Spondylitis

The Effects of Tele-Yoga in Ankylosing Spondylitis Patients

Start date: April 14, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of tele-yoga on functional level, disease activity, spinal mobility, balance, aerobic capacity, sleep quality, anxiety, depression, stress, mindfulness and quality of life in patients with ankylosing spondylitis

NCT ID: NCT04772976 Completed - Clinical trials for Ankylosing Spondylitis

Relationship Between Diet, Oxidative Stress and Inflammation in Ankylosing Spondylitis

Start date: November 16, 2020
Phase:
Study type: Observational

Ankylosing Spondylitis (AS) is a chronic inflammatory autoimmune disease. The aim of this study is to reveal the relationship between dietary intake, blood total antioxidant capacity and disease activity in individuals with AS. This study will include patients diagnosed with AS who applied to Ankara City Hospital Physical Therapy and Rehabilitation Hospital, and a control group that does not have AS. The sociodemographic characteristics and nutritional habits and 1-day physical activity status of individuals with AS and healthy persons will be recorded. Anthropometric measurements of all individuals (such as height length (cm) and body weight) will be taken. From the height and body weight measurements, the individuals body mass indexes will be calculated. All parts of the questionnaire for individuals included in the research will be filled in by the researcher through face-to-face interview technique. The disease activity score of the individuals in the case group will be evaluated by the physician. Serum biochemical parameters will be taken from the patient files. In the patient information system of the control group, above mentioned blood tests will be recorded from the examinations performed in the last 1 month. Serum total antioxidant and oxidant levels will be measured in a private laboratory with a tube (5 ml) of blood from all individuals. The parameters to be examined in blood samples are specific to the study and their cost will be covered by the researchers.

NCT ID: NCT04749537 Completed - Clinical trials for Ankylosing Spondylitis

Work Productivity and Social Activities In Patients With Ankylosing Spondylitis

Start date: April 15, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to evaluate the relationship between decrease in work productivity and social activities in patients with Ankylosing Spondylitis (AS) with disease activity, depression and quality of life together with demographic data.

NCT ID: NCT04746196 Completed - Clinical trials for Ankylosing Spondylitis

Galectin-3 Level in Ankylosing Spondylitis Patients

Start date: January 1, 2017
Phase:
Study type: Observational

Forty-five AS patients and 35 healthy controls were enrolled in this study. Patients diagnosed with AS according to Modified New York criteria were included in the study. Clinical and laboratory measurements, duration of symptoms, age and body mass index (BMI) of AS patients were performed and compared with age and BMI matched control group.

NCT ID: NCT04713813 Completed - Exercise Clinical Trials

Effectiveness of Hippotherapy Simulator in Ankylosing Spondylitis

Start date: January 13, 2021
Phase: N/A
Study type: Interventional

Recent studies and meta-analysis showed that different exercise plans had greater benefits than no invention group in improving pain, physical function, and disease activity, especially in some studies that involve ankylosing spondylitis patients receiving home-based exercise. Different kinds of exercises are efficacious and should be recommended to AS patients. But, according to our current knowledge, no clear protocols regarding the effectiveness of hippotherapy in AS patients. This study aims to investigate the effect of the therapeutic horseback riding therapy via a mechanical simulator on disease-specific outcomes and muscle strength of ankylosing spondylitis patients.